menu
    • menu

    Company profile for BioMarin Pharmaceutical

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    With seven products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs. At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission�...
    With seven products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs. At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioMarin PharmaceuticalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    770 Lindaro Street San Rafael, CA 94901
    Telephone
    Telephone
    415-506-6700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biomarin.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biomarin/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biomarin to Buy Amicus for $4.8 B in Rare Disease Bet
    Biomarin to Buy Amicus for $4.8 B in Rare Disease Bet

    19 Dec 2025

    // PRESS RELEASE

    https://investors.biomarin.com/news/news-details/2025/BioMarin-to-Acquire-Amicus-Therapeutics-for-4-8-Billion-Expanding-Position-as-a-Leader-in-Rare-Diseases-Accelerating-Revenue-Growth-and-Strengthening-Financial-Outlook/default.aspx

    PRESS RELEASE
    19 Dec 2025
    Share Share
    BioMarin Pharm's Pegvaliase-pqpz BLA Receives Approval in US
    BioMarin Pharm's Pegvaliase-pqpz BLA Receives Approval in US

    20 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    20 Nov 2025
    Share Share
    Biomarin To Present At Jefferies Global Healthcare Conference
    Biomarin To Present At Jefferies Global Healthcare Conference

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biomarin-to-participate-at-the-jefferies-global-healthcare-conference-on-tuesday-november-18-2025-at-1030-am-gmt-in-london-england-302610867.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    FDA Reviews Biomarin's Palynziq for Adolescent Phenylketonuria
    FDA Reviews Biomarin's Palynziq for Adolescent Phenylketonuria

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-accepts-biomarins-palynziq-pegvaliase-pqpz-supplemental-biologics-license-application-for-priority-review-to-expand-use-to-adolescents-aged-12-17-with-phenylketonuria-302597628.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    Biomarin Updates On Q3 2025 Results And Corporate Progress
    Biomarin Updates On Q3 2025 Results And Corporate Progress

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biomarin-reports-third-quarter-2025-results-and-provides-corporate-update-302595620.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Biomarin Pharma Plans To Divest Struggling Gene Therapy
    Biomarin Pharma Plans To Divest Struggling Gene Therapy

    27 Oct 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/biomarin-pharma-plans-divest-struggling-gene-therapy-2025-10-27/

    REUTERS
    27 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search